Tirilazad is a lazaroid and potent inhibitor of iron-dependent lipid peroxidation. Tirilazad has shown excellent activity in in vivo models of experimental central nervous system trauma & ischemia. Tirilazad protects brain tissue, and reduces brain damage on animal models. However, the drug fails to treat, and even worsens a stroke when studied on a human being.

110101-67-2

C39H56N6O5S

720.96

U74006F;U74006;U-74006F;U-74006;U 74006;U 74006F;Tirilazad mesylate

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years